sulforaphane has been researched along with Infections, Respiratory Syncytial Virus in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-sulforaphane (LSF) is an isothiocyanate derived from cruciferous vegetables that has long been known for its anticarcinogenic, antioxidant and anti-inflammatory effects." | 1.62 | The effects of the dietary compound L-sulforaphane against respiratory pathogens. ( Anderson, J; Do, LAH; Higgins, RA; Karagiannis, TC; Licciardi, PV; Luwor, RB; Mazarakis, N; Snibson, KJ; Toh, ZQ, 2021) |
| "Sulforaphane pretreatment significantly limited lung RSV replication and virus-induced inflammation in Nrf2(+/+) but not in Nrf2(-/-) mice." | 1.35 | Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. ( Cho, HY; Imani, F; Kleeberger, SR; Melendi, GA; Miller-DeGraff, L; Polack, FP; Walters, D; Yamamoto, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazarakis, N | 1 |
| Higgins, RA | 1 |
| Anderson, J | 1 |
| Toh, ZQ | 1 |
| Luwor, RB | 1 |
| Snibson, KJ | 1 |
| Karagiannis, TC | 1 |
| Do, LAH | 1 |
| Licciardi, PV | 1 |
| Cho, HY | 1 |
| Imani, F | 1 |
| Miller-DeGraff, L | 1 |
| Walters, D | 1 |
| Melendi, GA | 1 |
| Yamamoto, M | 1 |
| Polack, FP | 1 |
| Kleeberger, SR | 1 |
2 other studies available for sulforaphane and Infections, Respiratory Syncytial Virus
| Article | Year |
|---|---|
The effects of the dietary compound L-sulforaphane against respiratory pathogens.
Topics: Anti-Bacterial Agents; Cell Line; Cyclin D1; Haemophilus Infections; Haemophilus influenzae; Heme Ox | 2021 |
Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease.
Topics: Animals; Anticarcinogenic Agents; Bronchoalveolar Lavage Fluid; Buffers; Disease Models, Animal; Dru | 2009 |